Schneider K R, Müller G, Wiegelmann W, Solbach H G, Krüskemper H L
Klin Wochenschr. 1978 May 1;56(9):461-7. doi: 10.1007/BF01477061.
Growth hormone (GH) release was measured in 17 patients with active acromegaly following the administration of insulin, LH-RH and TRH given intravenously either combined or each separately. The simultaneous application of insulin and the hypothalamic releasing hormones resulted in a striking increase of plasma GH in 15 out of 17 patients. Inappropriate stimulation of GH release was found in 9 out of the 17 patients with acromegaly, when TRH was given as the only hormone; conversely this phenomenon due to LH-RH application was observed in 4 cases. In insulin-induced hypoglycemia GH release could be stimulated in 5 patients. After selective, transsphenoidal hypophysectomy, 4 of 13 patients still showed a definite stimulation of GH release after the combined use of test substances. Two of these also exhibited a comparable stimulation of GH after TRH, indicating adenoma cells remaining active after operation. The combined insulin-induced hypoglycemia/LH-RH/TRH-test is therefore advisable for patients with acromegaly, since GH release as well as other hypophyseal partial functions can be tested. The performance of individual tests is essential for evaluating selective stimulation of GH release.
对17例活动期肢端肥大症患者静脉注射胰岛素、促黄体生成素释放激素(LH-RH)和促甲状腺激素释放激素(TRH),联合用药或单独用药后,测定生长激素(GH)释放情况。胰岛素与下丘脑释放激素同时应用时,17例患者中有15例血浆GH显著升高。17例肢端肥大症患者中,单独给予TRH时,9例患者出现GH释放的不适当刺激;相反,应用LH-RH时,4例患者出现此现象。胰岛素诱导的低血糖症可刺激5例患者释放GH。选择性经蝶窦垂体切除术后,13例患者中有4例在联合使用测试物质后仍有明确的GH释放刺激。其中2例患者在给予TRH后也有类似的GH刺激,表明术后腺瘤细胞仍有活性。因此,联合胰岛素诱导的低血糖症/LH-RH/TRH试验对肢端肥大症患者是可取的,因为可以测试GH释放以及其他垂体部分功能。单独进行各项试验对于评估GH释放的选择性刺激至关重要。